A New Paradigm in Biotech Innovation and Investment
Asia-based biotech investment and venture capital were among the topics discussed at the Bio Asia-Taiwan international conference. We bring to you some key takeaways from the discussions.
Todd Kaloudis, Managing Director, Cobro Ventures, presented his views about why US venture capitalists (VCs) team up with Asia-based investors. Having worked with many in the past, he observes advantages in these collaborations.
GO Prime with only $1.49 now
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115